Industry News

The latest news from the clinical trials industry.

News Powered By:

- a collaborative partner.


Cromos Pharma launches risk-sharing partnerships program

CenterWatch News Online Headlines : December 19, 2014 8:33 am : Centerwatch

Portland, Ore.-based CRO Cromos Pharma, which operates predominantly in Eastern/Central Europe, has implemented a risk-sharing platform partnering with biotech, pharma and device companies with promising drug, biologics or medical device technologies.

14 indicted in connection with 2012 nationwide fungal meningitis outbreak

CenterWatch News Online Headlines : December 19, 2014 8:29 am : Centerwatch

The Justice Department unsealed a 131-count criminal indictment in Boston in connection with the 2012 nationwide fungal meningitis outbreak. Barry J. Cadden, owner and head pharmacist of New England Compounding Center (NECC), and NECC’s supervisory pharmacist Glenn A. Chin were charged with 25 acts of second-degree murder in Florida, Indiana, Maryland, Michigan, North Carolina, Tennessee and Virginia.   

Seven more research organizations earn AAHRPP accreditation

CenterWatch News Online Headlines : December 19, 2014 7:02 am : Centerwatch

The Association for the Accreditation of Human Research Protection Programs (AAHRPP) has accredited seven more organizations: four in the U.S. and three in Asia, including the first organization in Thailand.

Roche acquires Bina Technologies, enters genomic informatics market

CenterWatch News Online Headlines : December 19, 2014 7:00 am : Centerwatch

Roche has acquired Bina Technologies, a privately held company based in Redwood City, Calif. Bina provides a big data platform for centralized management and processing of next generation sequencing (NGS) data. Bina’s proprietary on-market Genomic Management Solution, Bina-GMS, empowers basic, translational and academic researchers to perform fast and scalable analyses to maximize the value of genomic data.

Merck acquires OncoEthix, a privately-held oncology company

CenterWatch News Online Headlines : December 19, 2014 6:06 am : Centerwatch

Merck has acquired, through a subsidiary, OncoEthix, a Swiss-based, privately held biotechnology company specializing in oncology drug development. Merck has gained an investigational, novel oral BET (bromodomain) inhibitor, OTX015, currently in phase Ib studies for the treatment of hematological malignancies and advanced solid tumors.

« Page 1, 2, 3511, »